Your browser doesn't support javascript.
loading
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses.
Daly, John; Sarkar, Subhashis; Natoni, Alessandro; Stark, Jessica C; Riley, Nicholas M; Bertozzi, Carolyn R; Carlsten, Mattias; O'Dwyer, Michael E.
Afiliação
  • Daly J; Apoptosis Research Center, National University of Ireland, Galway, Ireland.
  • Sarkar S; Apoptosis Research Center, National University of Ireland, Galway, Ireland.
  • Natoni A; Apoptosis Research Center, National University of Ireland, Galway, Ireland.
  • Stark JC; Department of Chemistry and Stanford ChEM-H, Stanford University, Stanford, CA.
  • Riley NM; Department of Chemistry and Stanford ChEM-H, Stanford University, Stanford, CA.
  • Bertozzi CR; Department of Chemistry and Stanford ChEM-H, Stanford University, Stanford, CA.
  • Carlsten M; Howard Hughes Medical Institute, Stanford University, Stanford, CA; and.
  • O'Dwyer ME; Center for Haematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
Blood Adv ; 6(11): 3352-3366, 2022 06 14.
Article em En | MEDLINE | ID: mdl-35294519
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article